Bal Pharma Limited (BALPHARMA.BO)
INR 106.04
(1.49%)
INR 106.04
(1.49%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 3.39 Billion | 3.01 Billion | 2.79 Billion | 2.46 Billion | 1.67 Billion | 2.2 Billion |
| Cost of Revenue | 2.62 Billion | 1.73 Billion | 1.67 Billion | 1.52 Billion | 849.34 Million | 1.2 Billion |
| Gross Profit | 770.19 Million | 1.28 Billion | 1.11 Billion | 942.27 Million | 827.4 Million | 1 Billion |
| Operating Expenses | 389.89 Million | 1.1 Billion | 968.2 Million | 771.39 Million | 853.75 Million | 887.76 Million |
| Selling, General and Administrative Expenses | 361.4 Million | 88.29 Million | 75.91 Million | 62.74 Million | 89.24 Million | 131.73 Million |
| Research and Development Expenses | - | - | - | 185 Thousand | 28.3 Million | 16.41 Million |
| Other Expenses | 28.48 Million | 5.76 Million | 17.33 Million | 7.72 Million | 9.43 Million | 965 Thousand |
| Cost and Expenses | 3.15 Billion | 2.84 Billion | 2.64 Billion | 2.29 Billion | 1.7 Billion | 2.09 Billion |
| Operating Income | 233.9 Million | 177.23 Million | 149.17 Million | 140.64 Million | -55.76 Million | 79.63 Million |
| Interest Expense | 152.57 Million | 104.96 Million | 88.75 Million | 105.39 Million | 107.74 Million | 108.89 Million |
| Income Tax Expense | 16.01 Million | 21.29 Million | 34.77 Million | -6.09 Million | -6.37 Million | -23.55 Million |
| Earnings before Tax | 90.47 Million | 47.48 Million | 91.82 Million | 41.02 Million | -135.29 Million | -2.02 Million |
| Net Income | 73.92 Million | 25.71 Million | 56.11 Million | 47.42 Million | -122.18 Million | 37.88 Million |
| Earnings Per Share Basic | 4.94 | 1.64 | 3.79 | 3.34 | -8.62 | 2.67 |
| Earnings Per Share Diluted | 4.94 | 1.64 | 3.71 | 3.34 | -8.62 | 2.67 |
| Weighted Average Shares Outstanding | 14.96 Million | 15.69 Million | 14.82 Million | 14.19 Million | 14.17 Million | 14.17 Million |
| Weighted Average Shares Outstanding (Diluted) | 14.96 Million | 15.69 Million | 15.14 Million | 14.19 Million | 14.17 Million | 14.17 Million |
| Gross Margin | 0.23 | 0.43 | 0.40 | 0.38 | 0.49 | 0.45 |
| EBIT Margin | 0.10 | 0.08 | 0.09 | 0.10 | 0.03 | 0.08 |
| Profit Margin | 0.02 | 0.01 | 0.02 | 0.02 | -0.07 | 0.02 |
| EBITDA | 345.59 Million | 244.99 Million | 287.64 Million | 257.82 Million | 68.8 Million | 186.92 Million |
| Earnings Before Tax Margin | 0.07 | 0.06 | 0.05 | 0.06 | -0.03 | 0.04 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 743.58 Million | 3.39 Billion | 946.26 Million | 816.63 Million | 925.42 Million | 701.65 Million |
| Cost of Revenue | 564.13 Million | 2.62 Billion | 715.57 Million | 458.47 Million | 533.14 Million | 387.9 Million |
| Gross Profit | 179.45 Million | 770.19 Million | 230.68 Million | 358.16 Million | 392.28 Million | 313.75 Million |
| Operating Expenses | 139.08 Million | 555.62 Million | 156.31 Million | 309.84 Million | 339.49 Million | 266.56 Million |
| Selling, General and Administrative Expenses | 139.08 Million | - | 156.31 Million | 127.64 Million | 162.32 Million | 109.34 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 8.18 Million | 28.48 Million | 24.54 Million | 953 Thousand | 1.42 Million | 4.47 Million |
| Cost and Expenses | 703.21 Million | 3.17 Billion | 871.89 Million | 768.31 Million | 872.64 Million | 654.46 Million |
| Operating Income | 40.37 Million | 214.56 Million | 74.36 Million | 49.26 Million | 52.78 Million | 39.1 Million |
| Interest Expense | 42.38 Million | 152.57 Million | 41.39 Million | 36.6 Million | 38.21 Million | 36.35 Million |
| Income Tax Expense | 3.58 Million | 16.01 Million | 2.18 Million | 4.16 Million | 6.29 Million | 3.35 Million |
| Earnings before Tax | 6.17 Million | 90.47 Million | 57.51 Million | 12.66 Million | 15.99 Million | 15.31 Million |
| Net Income | 2.59 Million | 73.92 Million | 54.73 Million | 8.88 Million | 9.45 Million | 11.95 Million |
| Earnings Per Share Basic | 0.16 | - | 3.73 | 0.56 | 0.60 | 0.76 |
| Earnings Per Share Diluted | 0.16 | - | 3.73 | 0.56 | 0.60 | 0.76 |
| Weighted Average Shares Outstanding | 15.8 Million | 15.8 Million | 15.8 Million | 15.8 Million | 15.68 Million | 15.68 Million |
| Weighted Average Shares Outstanding (Diluted) | 15.8 Million | 15.8 Million | 15.8 Million | 15.8 Million | 15.68 Million | 15.68 Million |
| Gross Margin | 0.24 | 0.23 | 0.24 | 0.44 | 0.42 | 0.45 |
| EBIT Margin | 0.09 | - | 0.10 | 0.10 | 0.08 | 0.10 |
| Profit Margin | 0.00 | 0.02 | 0.06 | 0.01 | 0.01 | 0.02 |
| EBITDA | 64.65 Million | - | 95.91 Million | 78.89 Million | 78.39 Million | 72.89 Million |
| Earnings Before Tax Margin | 0.05 | 0.06 | 0.08 | 0.06 | 0.06 | 0.06 |
DII-B
PDS
HYPMY
HDYNQ
FSTR
TOP-R